Haleon Pakistan Limited has successfully sent its first shipment of Centrum multivitamins from its Jamshoro facility to Kenya. This marks an important step in expanding Pakistan’s pharmaceutical exports and strengthening its position in global markets.
The company shared this achievement in a notice to the Pakistan Stock Exchange, expressing gratitude to the Special Investment Facilitation Council (SIFC) and other authorities for their support. Their assistance played a key role in making this export possible.
Pakistan’s pharmaceutical industry has been growing internationally, and this shipment reflects its increasing contribution to global healthcare. By exporting Centrum multivitamins to Kenya, Haleon Pakistan is helping build a positive reputation for Pakistani-made health products.
This milestone is expected to create new opportunities for pharmaceutical exports from Pakistan. As demand for high-quality medicines and supplements continues to rise, more Pakistani companies can explore international markets. With the right support from the government and investment councils, the pharmaceutical sector has the potential to expand further.
Haleon Pakistan’s success in reaching Kenya is just the beginning. The company is likely to explore more countries, further strengthening Pakistan’s presence in the global pharmaceutical industry. This achievement highlights the ability of Pakistani pharmaceutical companies to compete internationally, contributing to both business growth and economic progress.
With continued efforts and support, Pakistan’s pharmaceutical industry can establish itself as a key player in global markets, bringing benefits to both the country’s economy and healthcare sector.
